Reuters logo
BRIEF-Pain Therapeutics announces upcoming meeting with FDA
October 30, 2017 / 12:12 PM / 24 days ago

BRIEF-Pain Therapeutics announces upcoming meeting with FDA

Oct 30 (Reuters) - Pain Therapeutics Inc

* Pain Therapeutics announces upcoming meeting with FDA

* Pain Therapeutics - ‍U.S. FDA agreed to pre-nda guidance meeting to discuss co’s NDA resubmission for remoxy er as a treatment for severe chronic pain​

* Pain Therapeutics Inc - ‍meeting is planned for November 14, 2017 at FDA headquarters​

* Pain Therapeutics Inc - ‍remoxy NDA remains on-track for a planned resubmission in Q1 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below